View of A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA

Return to Article Details A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA Download Download PDF